CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $20.28M, above the global median of $18.73M
- PositionReturn on equity is 42%, higher than 95% of its Health Information Services peers (median 0.4%)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
3.27%Above 5Y avg (2.06%)
Annual Rate
USD 0.64Paid quarterly
Payout Ratio
250.0%High
Consecutive Growth
1 yr
Paying Dividends
13 yr
Payback Period
31.8 yr
Last Ex-Dividend
Sep 25, 2026
Next Payment
Oct 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
432.88MUSDvs all stocks (USD)
Trailing P/E
81.54xvs Health Information Services peers
Revenue (TTM)
140.00MUSDvs all stocks (USD)
Profit Margin
4.18%vs Health Information Services peers
Beta
0.3770xvs all stocks
52-Week Change
53.25%vs all stocks
Forward Annual Dividend Yield
3.27%vs all stocks
Market Capitalization
432.88MUSDvs all stocks (USD)
Enterprise Value
520.00MUSDvs all stocks (USD)
Trailing P/E
81.54xvs Health Information Services peers
Forward P/E
18.64xvs Health Information Services peers
PEG Ratio
0.0582xPrice to Sales (TTM)
3.09xvs Health Information Services peers
Price to Book (MRQ)
66.11xvs Health Information Services peers
Enterprise to Revenue
3.71xvs Health Information Services peers
Enterprise to EBITDA
19.49xvs Health Information Services peers
Gross Margin
61.67%vs Health Information Services peers
Profit Margin
4.18%vs Health Information Services peers
Operating Margin
-0.22%vs Health Information Services peers
Return on Assets (TTM)
8.13%vs Health Information Services peers
Return on Equity (TTM)
42.03%vs Health Information Services peers
Revenue (TTM)
140.00MUSDvs all stocks (USD)
Revenue per Share (TTM)
6.38USDUpdated Sep 28, 2026Quarterly Revenue Growth
4.00%vs Health Information Services peers
Gross Profit (TTM)
86.45MUSDvs all stocks (USD)
EBITDA (TTM)
30.23MUSDvs all stocks (USD)
Net Income (TTM)
5.48MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
29.51MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
20.28MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.6400USDUpdated Sep 28, 2026Forward Annual Dividend Yield
3.27%vs all stocks
Trailing Annual Dividend Rate
0.6400USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
3.27%vs all stocks
5-Year Average Dividend Yield
2.06%vs all stocks
Payout Ratio
250.00%vs Health Information Services peers
Revenue
137.39MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
52.37MUSDFY2025 · Dec 31, 2025Gross Profit
85.02MUSDFY2025 · Dec 31, 2025Operating Income
22.59MUSDvs all stocks (USD)
Pre-tax Income
17.84MUSDFY2025 · Dec 31, 2025Income Tax Expense
6.25MUSDFY2025 · Dec 31, 2025Net Income
11.60MUSDFY2025 · Dec 31, 2025EBIT
22.61MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
30.23MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
54.80MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
111.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.76MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.5000USDFY2025 · Dec 31, 2025EPS (Diluted)
0.5000USDFY2025 · Dec 31, 2025Basic Shares Outstanding
22.38MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
22.38MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
11.60MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
308.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
24.63MUSDFY2025 · Dec 31, 2025Free Cash Flow
13.92MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.14MUSDFY2025 · Dec 31, 2025Interest Paid
4.49MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
11.60MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
7.62MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
2.63MUSDFY2025 · Dec 31, 2025Stock-based Compensation
3.31MUSDFY2025 · Dec 31, 2025Other Non-cash Items
243.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-53.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
170.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-895.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-10.71MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-10.71MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
84.68MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-68.44MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-20.18MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-10.98MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.06MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.97MUSDFY2025 · Dec 31, 2025Shares Outstanding
22.14MSharesUpdated Sep 28, 2026Float Shares
11.82MSharesUpdated Sep 28, 2026Shares Short
685.38KSharesUpdated Sep 28, 2026Short Ratio
5.79daysvs all stocks
Short % of Shares Outstanding
28.48%vs all stocks
% Held by Insiders
49.79%vs all stocks
% Held by Institutions
50.37%vs all stocks
Total Cash (MRQ)
3.33MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.1500USDUpdated Sep 28, 2026Total Debt (MRQ)
90.45MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
13.81xvs Health Information Services peers
Current Ratio (MRQ)
0.6510xvs Health Information Services peers
Book Value per Share (MRQ)
0.2960USDUpdated Sep 28, 2026Total Assets
134.88MUSDvs all stocks (USD)
Total Current Assets
20.21MUSDFY2025 · Dec 31, 2025Total Liabilities
120.89MUSDFY2025 · Dec 31, 2025Total Non-current Assets
114.67MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
84.27MUSDFY2025 · Dec 31, 2025Total Current Liabilities
36.62MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.14MUSDFY2025 · Dec 31, 2025Accounts Receivable
11.11MUSDFY2025 · Dec 31, 2025Accounts Payable
1.17MUSDFY2025 · Dec 31, 2025Short-term Debt
4.01MUSDFY2025 · Dec 31, 2025Deferred Revenue
16.20MUSDFY2025 · Dec 31, 2025Other Current Liabilities
946.00KUSDFY2025 · Dec 31, 2025Long-term Debt
75.02MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
3.26MUSDFY2025 · Dec 31, 2025Common Stock (Book)
32.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-17.30MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
13.99MUSDvs all stocks (USD)
Treasury Stock
152.62MUSDFY2025 · Dec 31, 202552-Week Low
11.01USDUpdated Sep 28, 202652-Week High
23.68USDUpdated Sep 28, 202652-Week Change
53.25%vs all stocks
Beta
0.3770xvs all stocks
50-Day MA
21.11USDUpdated Sep 28, 2026200-Day MA
18.86USDUpdated Sep 28, 2026Avg 10-Day Volume
136.55KSharesUpdated Sep 28, 2026Avg 30-Day Volume
126.56KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
0.2400USDUpdated Sep 28, 2026Other Income / Expense
-95.00KUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Cumulative Treasury Stock Significant With Elevated ROE And FCF-To-Equity
It has bought back shares for years, and its equity earns more than its industry and yields heavy free cash flow.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 42%, higher than 95% of its Health Information Services peers (median 0.4%)Significant
Return on equity: 0.42Industry median: 0.00Industry P95: 0.36Peers compared: 32.00
Debt-to-equity is 13.81×, higher than 95% of its Health Information Services peers (median 0.13×)Significant
Debt-to-equity: 13.81Industry median: 0.13Industry P95: 1.96Peers compared: 32.00
Price-to-book is 66.11×, higher than 95% of its Health Information Services peers (median 2.59×)Significant
Price-to-book: 66.11Industry median: 2.59Industry P95: 25.56Peers compared: 32.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.50Dividend per Share: 0.64Earnings per Share: 0.24
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: 0.04
Financial Health
Altman Z-Score 3.39: safe zoneNotable
Altman Z-Score: 3.39
High earnings qualityNotable
Earnings Quality Score: 0.81
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Levered free cash flow is $20.28M, above the global median of $18.73MNotable
Levered free cash flow (USD): 20,282,000Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Japan Business Systems Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Bonree Data Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Avant Group Corporation
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Computer Engineer & Consulting Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Datasection Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Beijing Forever Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Lunit Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
CI&T Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Simulations Plus, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Bairong Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Dexcom Inc.
2 interpretationsCumulative Treasury Stock Significant With Elevated ROE And FCF-To-EquityROE, ROA, And Operating ROA Elevated
Inter Parfums, Inc.
1 interpretationROE, ROA, And Operating ROA Elevated